# US 2022/0325302 A1 · Adeno-associated virus compositions for restoring pah gene function and methods of use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0325302 A1
- Document ID: US20220325302A1
- Status: Published application
- Kind: A1
- Application number: 17/656,562
- Filed: 2022-03-25
- Published: 2022-10-13
- Earliest claimed: 2018-02-01
- Assignees: Homology Medicines, Inc.
- Applicants: Homology Medicines, Inc.
- Inventors: Albert Barnes SEYMOUR; Seemin Seher AHMED; Jason Boke WRIGHT; Serena Nicole DOLLIVE; James Anthony MCSWIGGEN; Jaime Michelle PROUT; Danielle Lauren SOOKIASIAN
- Web page: https://patentgrep.com/patent/US20220325302A1

## CPC

- C12N 15/907: {in mammalian cells}
- C12Y 114/16001: Phenylalanine 4-monooxygenase (1.14.16.1)
- A61K 35/761: Adenovirus
- A61K 48/005: {characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered}
- C12N 7/00: Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K39/00)
- A01K 2217/072: maintaining or altering function, i.e. knock in
- A01K 2217/075: inducing loss of function, i.e. knock out
- A01K 2227/105: Murine
- A01K 2267/0306: Animal model for genetic diseases
- C12N 2710/10033: Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
- C12N 2710/10052: relating to complementing cells and packaging systems for producing virus or viral particles
- C12N 2750/14121: Viruses as such, e.g. new isolates, mutants or their genomic sequences
- C12N 2750/14143: viral genome or elements thereof as genetic vector
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A01K: ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS

## Abstract

Provided herein are adeno-associated virus (AAV) compositions that can restore phenylalanine hydroxylase (PAH) gene function in cell. Also provided are methods of use of the AAV compositions, and packaging systems for making the AAV compositions.

## Claims

### Claim 1

A polynucleotide comprising: a nucleotide sequence that is at least 99% identical to the nucleotide sequence set forth in positions 7-871 of SEQ ID NO: 130; or a nucleotide sequence that is at least 96% identical to the nucleotide sequence set forth in positions 7-589 of SEQ ID NO: 127.

### Claim 2 (depends on 1)

The polynucleotide of claim 1, comprising a nucleotide sequence that is at least 99% identical to the nucleotide sequence set forth in positions 7-871 of SEQ ID NO: 130.

### Claim 3 (depends on 1)

The polynucleotide of claim 1, comprising the nucleotide sequence set forth in positions 7-871 of SEQ ID NO: 130.

### Claim 4 (depends on 1)

The polynucleotide of claim 1, comprising the nucleotide sequence of SEQ ID NO: 130.

### Claim 5 (depends on 1)

The polynucleotide of claim 1, comprising a nucleotide sequence that is at least 96% identical to the nucleotide sequence set forth in positions 7-589 of SEQ ID NO: 127.

### Claim 6 (depends on 1)

The polynucleotide of claim 1, comprising the nucleotide sequence set forth in positions 7-589 of SEQ ID NO: 127.

### Claim 7 (depends on 1)

The polynucleotide of claim 1, comprising the nucleotide sequence of SEQ ID NO: 127.

### Claim 8

A vector comprising a polynucleotide that comprises:
a) a nucleotide sequence that is at least 99% identical to the nucleotide sequence set forth in positions 7-871 of SEQ ID NO: 130;
b) the nucleotide sequence set forth in positions 7-871 of SEQ ID NO: 130;
c) the nucleotide sequence of SEQ ID NO: 130;
d) a nucleotide sequence that is at least 96% identical to the nucleotide sequence set forth in positions 7-589 of SEQ ID NO: 127;
e) the nucleotide sequence set forth in positions 7-589 of SEQ ID NO: 127; or
f) the nucleotide sequence of SEQ ID NO: 127.

### Claim 9 (depends on 8)

The vector of claim 8, which is an adeno-associated virus (AAV) vector.

### Claim 10

A cell comprising a polynucleotide that comprises:
a) a nucleotide sequence that is at least 99% identical to the nucleotide sequence set forth in positions 7-871 of SEQ ID NO: 130;
b) the nucleotide sequence set forth in positions 7-871 of SEQ ID NO: 130;
c) the nucleotide sequence of SEQ ID NO: 130;
d) a nucleotide sequence that is at least 96% identical to the nucleotide sequence set forth in positions 7-589 of SEQ ID NO: 127;
e) the nucleotide sequence set forth in positions 7-589 of SEQ ID NO: 127; or
f) the nucleotide sequence of SEQ ID NO: 127.

### Claim 11 (depends on 8)

A cell comprising the vector of claim 8.

### Claim 12 (depends on 9)

A cell comprising the vector of claim 9.

### Claim 13 (depends on 10)

The cell of claim 10, which is a mammalian cell or an insect cell.

### Claim 14 (depends on 11)

The cell of claim 11, which is a mammalian cell or an insect cell.

### Claim 15 (depends on 12)

The cell of claim 12, which is a mammalian cell or an insect cell.
